Anterior nerve cell disease

Latest Articles

Special Article
Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
David Michelson, Emma Ciafaloni, Stephen Ashwal, et al.

Neurology October 12, 2018
Article
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1A cohort study
Karolina Aragon-Gawinska, Andreea M. Seferian, Aurore Daron, et al.

Neurology August 29, 2018
Editorial
Harnessing the power of the patient perspective for rare disease therapeutics
Kathryn J. Swoboda, Flavia C. Nery

Neurology August 24, 2018
Article
Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA)
Phillip Mongiovi, Nuran Dilek, Connie Garland, et al.

Neurology August 24, 2018